Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fiyyaz Ahmed-Jushuf

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Journal of Arrhythmia|April 23, 2019
The impact of the presence of left atrial low voltage areas on outcomes from pulmonary vein isolationFiyyaz Ahmed-Jushuf, Francis Murgatroyd, Para Dhillon, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|April 1, 2025
Angina in stable coronary artery disease: Data from ORBITA and ORBITA-2Shayna Chotai, Ahmed Salih, Fiyyaz Ahmed-Jushuf, et al.
Neurobiology of Aging|May 5, 2016
Age-dependent expression of VEGFR2 in deep brain arteries in small vessel disease, CADASIL, and healthy brainsFiyyaz Ahmed-Jushuf, Nadim S Jiwa, Anum S Arwani, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|January 8, 2025
A systematic review of enrolment criteria and treatment efficacy for microvascular anginaMatthew Hammond-Haley, Kayla Chiew, Fiyyaz Ahmed-Jushuf, et al.
JACC. Cardiovascular Interventions|August 13, 2025
Safety, Efficacy, and Effectiveness of Coronary Sinus Reducer Implantation in Refractory Angina: A Meta-AnalysisUtkarsh Ojha, Muhammad Mohsin, Krzysztof Macierzanka, et al.
Journal of the American Heart Association|April 5, 2019
Long-Term Outcomes Following Heart Team Revascularization Recommendations in Complex Coronary Artery DiseaseTiffany Patterson, Hannah Z R McConkey, Fiyyaz Ahmed-Jushuf, et al.
Open Heart|June 15, 2021
Coagulation derangement and risk factors for valve thrombosis following transcatheter aortic valve implantationTiffany Patterson, Harriet Hurrell, Jack Lee, et al.
JAMA Surgery|April 17, 2024
Placebo Control and Blinding in Randomized Trials of Procedural Interventions: A Systematic Review and Meta-RegressionChristopher A Rajkumar, Katharine E Thomas, Michael Foley, et al.
American Journal of Respiratory Cell and Molecular Biology|June 13, 2018
Lung Defense through IL-8 Carries a Cost of Chronic Lung Remodeling and Impaired FunctionCatherine J Reynolds, Kathryn Quigley, Xiaoming Cheng, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|January 12, 2024
A double-blind, randomised, placebo-controlled trial of the coronary sinus Reducer in refractory angina: design and rationale of the ORBITA-COSMIC trialMichael J Foley, Christopher A Rajkumar, Fiyyaz Ahmed-Jushuf, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Journal of Arrhythmia|April 23, 2019
The impact of the presence of left atrial low voltage areas on outcomes from pulmonary vein isolationFiyyaz Ahmed-Jushuf, Francis Murgatroyd, Para Dhillon, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|April 1, 2025
Angina in stable coronary artery disease: Data from ORBITA and ORBITA-2Shayna Chotai, Ahmed Salih, Fiyyaz Ahmed-Jushuf, et al.
Neurobiology of Aging|May 5, 2016
Age-dependent expression of VEGFR2 in deep brain arteries in small vessel disease, CADASIL, and healthy brainsFiyyaz Ahmed-Jushuf, Nadim S Jiwa, Anum S Arwani, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|January 8, 2025
A systematic review of enrolment criteria and treatment efficacy for microvascular anginaMatthew Hammond-Haley, Kayla Chiew, Fiyyaz Ahmed-Jushuf, et al.
JACC. Cardiovascular Interventions|August 13, 2025
Safety, Efficacy, and Effectiveness of Coronary Sinus Reducer Implantation in Refractory Angina: A Meta-AnalysisUtkarsh Ojha, Muhammad Mohsin, Krzysztof Macierzanka, et al.
Journal of the American Heart Association|April 5, 2019
Long-Term Outcomes Following Heart Team Revascularization Recommendations in Complex Coronary Artery DiseaseTiffany Patterson, Hannah Z R McConkey, Fiyyaz Ahmed-Jushuf, et al.
Open Heart|June 15, 2021
Coagulation derangement and risk factors for valve thrombosis following transcatheter aortic valve implantationTiffany Patterson, Harriet Hurrell, Jack Lee, et al.
JAMA Surgery|April 17, 2024
Placebo Control and Blinding in Randomized Trials of Procedural Interventions: A Systematic Review and Meta-RegressionChristopher A Rajkumar, Katharine E Thomas, Michael Foley, et al.
American Journal of Respiratory Cell and Molecular Biology|June 13, 2018
Lung Defense through IL-8 Carries a Cost of Chronic Lung Remodeling and Impaired FunctionCatherine J Reynolds, Kathryn Quigley, Xiaoming Cheng, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|January 12, 2024
A double-blind, randomised, placebo-controlled trial of the coronary sinus Reducer in refractory angina: design and rationale of the ORBITA-COSMIC trialMichael J Foley, Christopher A Rajkumar, Fiyyaz Ahmed-Jushuf, et al.
Pageof 3